INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹1,566 Cr | ₹1,581 Cr | ₹1,383 Cr | ₹1,215 Cr | ₹1,023 Cr |
What is the latest Total Expenditure of INDOCO REMEDIES ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹1,566 Cr |
| Mar2024 | ₹1,581 Cr |
| Mar2023 | ₹1,383 Cr |
| Mar2022 | ₹1,215 Cr |
| Mar2021 | ₹1,023 Cr |
How is Total Expenditure of INDOCO REMEDIES Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,566 Cr | -0.96 | |
| Mar2024 | ₹1,581 Cr | 14.34 | |
| Mar2023 | ₹1,383 Cr | 13.84 | |
| Mar2022 | ₹1,215 Cr | 18.70 | |
| Mar2021 | ₹1,023 Cr | - | |
Compare Total Expenditure of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹1,843.7 Cr | -7.2% | -7% | -21.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -7.2% |
-7% |
-21.8% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses